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Among the  substances  known  to produce  systolic contracture  of the  frog's 
heart are:  (a) vegetable poisons, notably the  glycosides of the digitalis group 
(1) and saponins (2); (b) animal venoms such as. those of the toad (3), the cobra, 
and other snakes (4);  (c)  certain bacterial toxins  (5);  (d) oxidizing agents (6). 
Some  of  these  substances  are  also  hemolytic,  the  association  of  hemolytic 
activity with cardiotoxic substances appearing to be rather frequent and wide- 
spread in naturally occurring materials. 
The  toxic effects of  the  most  thoroughly  studied  bacterial toxins,  such  as 
tetanus toxin (tetanospasmin) and diphtheria toxin, develop only after a latent 
period of considerable length, while the toxic effects which follow the intravenous 
injection of the toxins of Clostridium  welchii, C1. septicum,  and staphylococcus 
develop almost immediately.  It may be noted  that  all of the  toxins  of  tile 
latter group are hemolytic in vitro while the slow acting toxins are not hemolytic. 
Dale, in an appendix to a paper by Robertson (7), suggested that the toxin of C1. 
septlcum has two effects on the cardiovascular system of rabbits: a pressor action and 
also a direct toxic action on the heart muscle.  Lautenschl~tger (5) in a more extended 
study confirmed  Dale's suggestion  of a  cardiotoxic action.  Using unconcentrated 
filtrates  of  Cl. septicum cultures  he  analyzed the  circulatory collapse  that  follows 
intravenous administration of the toxin and found that death is due to the cardiac 
action of the toxin.  He was impressed by the superficial  resemblance of the action 
of the toxin to that of the digitalis  glycosides  on the mammalian heart and the iso- 
lated frog's heart.  The pharmacology of the toxins of the gas gangrene organisms was 
further studied  by Buttle  and Trevan  (8)  and  by Kellaway, Reid,  and Trethewie 
(9).  The latter authors verified the correctness of Dale's suggestions  and attributed 
the complex circulatory effects  of the  toxin partly to a  specific cardiac action and 
partly to constriction of pulmonary and coronary vessels.  In addition to the obser- 
vations  on  C1.  septlcum toxin,  staphylococcal toxin  has been found  by Kellaway, 
Burnet,  and Williams  (10) to produce acute circulatory symptoms and by Dingle, 
Hoff, Nahum,  and  Carey  (11) to  produce  acute  myocardial damage.  The  eircu- 
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latory symptoms according to Feldberg and Keogh (12) can be attributed  to the lib- 
eration  of histamine. 
While engaged in a  study of the pharmacological actions of the toxins of the 
anaerobic  spore-forming  bacilli,  we  confirmed  the  observations  just  cited  of 
Lautenschl~ger  on  the  frog's heart.  It  appeared  worth  while  to  investigate 
the possible association of hemolytic and cardiotoxic activity of the hemolysins 
of bacteria other than the sporulating anaerobes.  The oxygen-labile hemolysin 
of  Streptococcus  pyogenes  was  selected  because  it  has  been  studied  more 
thoroughly  than  most  other  bacterial  hemolysins.  The  observations  of  the 
action on  the isolated frog's heart  of this hemolysin  (or of a  substance  closely 
related  to  it)  form the  subject  of the present  communication. 
Methods and Materials 
Most of the experiments were performed in the months of July, August, and September on 
isolated hearts of Rana pipiens prepared according to Straub's technique (13).  A straight 
Fiihner cannula with a capacity of 1.2 cc. was used. 
The physiological solution used in all experiments had the following composition: NaCI 
0.65 per cent, KC1 0.01 per cent, CaC12 (anhydrous) 0.01 per cent.  The pH of the solution 
was maintained at 7.4 with phosphate buffer in a final concentration of 0.00345  M.  A fine 
stream of oxygen was bubbled through the fluid in the cannula.  All experiments were con- 
ducted  at room temperature. 
Preparation of Hemolysin-Containing Fraction of Culture Supernate  Used in the l~xperi- 
ments.--The smooth variant of Streptococcus pyogenes, strain  C203S,  was grown in  10 liter 
cultures according to the method described by Bernheimer,  Gillman, Hottle, and Pappen- 
heimer (14).  This method was employed because the biologically active substances produced 
by the streptococci can be obtained in good yield and because the isolation of these substances 
is facilitated by the use of a medium which is free from extraneous substances of high molecu- 
lar  weight. 
After frequent neutralization of the acid formed over a 20 hour period of growth, the cul- 
tures were refrigerated overnight and centrifuged on the following day.  The supematant 
fluids, to which were added a  few drops of toluene, were concentrated five- to eighffold in 
large cellophane sacs suspended in a current of air.  The concentrates were  dialyzed over- 
night against half-saturated ammonium sulfate in the cold, followed by dialysis against run- 
ning tap-water.  The concentrates were next dialyzed against saturated ammonium sulfate 
in the cold for 4 to 6 days at the end of which time precipitation was complete.  The precip- 
itates were collected by centrifugation and were stored in the refrigerator under a small vol- 
ume of saturated ammonium sulfate.  The over-all reduction in volume was approximately 
300-fold. 
The hemolytic potency of the concentrates was tested in a manner similar to that described 
elsewhere (15) except that the hemolysin was activated with 1 per cent cysteine before dilu- 
tions were made.  The hemolytic unit is the amount of hemolysin which liberates half the 
total hemoglobin contained in 1 cc. of a 0.7 per cent suspension of washed human erythro- 
cytes, in a  final volume of 2 cc.  The average hemolytic potency of the concentrates was 
100,000 units per cc.  It was observed that the erythrocytes developed increased resistance 
to lysis by streptococcal hemolysin whe~ the cell suspension was stored for more than a day 
or so in the cold.  For this reason, freshly prepared  cell suspensions were used whenever 
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Preparatory to testing on the frog's heart, a portion of the concentrated culture supernate 
was dialyzed free of ammonium sulfate, centrifuged at high speed in order to remove residual 
cells,  and stored in  the cold without further purification,  The dialyzed concentrates un- 
doubtedly contained a  mixture of streptococcal products in addition to hemolysin and for 
this reason they are noncommittally referred to as SPA (streptococcal preparation A).  As 
will be shown in a later section the substance in SPA which acts on the frog's heart is activated 
by cysteine.  Unless otherwise indicated, SPA in a  concentration of 1:100  was always ac- 
tivated in the cold with cysteine (1:1000)  for 10 minutes.  The activated SPA was further 
diluted with Ringer's solution so that the concentration of the cysteine in the solution finally 
applied to the heart was 1:2500. 
FIG. 1.  Comparison of the effects of Clostridium septicum toxin and streptococcal prepara- 
tion A (SPA).  Isolated frog's heart (Straub) suspended on Ftihner's cannula: Ringer's solu- 
tion 1.2 cc.  Kymographic record of amplitude of ventricular contraction. 
(A)  The effect of Clostridium septicum  toxin: At arrow Clostridium septicum  toxin  1:35 
added.  Figures indicate in minutes the periods of arrest of the drum. 
(B)  The effect of streptococcal  preparation A: At arrow SPA 1 : 25 in cysteine 1 : 1000 added. 
R, washing with Ringer's solution.  Figures indicate in minutes the periods of arrest of the 
drum. 
EXPERIMENTAL 
Comparison of Effects Produced by Cl. septicum Toxin and by SPA.- 
The supernatant fluid from a culture of C1. septicum grown in a peptone-free medium (16) 
was applied to the heart in a  dilution of 1:35.  After 8 minutes, the systole and diastole 
started to decrease (Fig. 1A), and continued progressively to do so during the next 20 minutes, 
at the end of which time the ventricle had stot~ped beating midway between systole and di- 
astole.  The auricles were distended with fluid and continued to beat after the ventricle had 
stopped. 
These observations are similar to those recorded by Lautenschl~ger (5). 
The dialyzed streptococcal concentrate prepared as already described was diluted 25 times 
in Ringer's fluid containing cysteine in a concentration of 1 : 1000.  After 2 minutes at room 
temperature this solution was administered to the heart and allowed to remain in the heart 
for 23 minutes.  It was found to have no effect other than a slight increase in amplitude of 
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experiments in which concentrations of SPA varying from 1 : 25 to 1 : 1000 were used.  A small 
proportion of the hearts, less than one in twenty, unpredictably developed systolic contracture, 
indistinguishable from that described in the next paragraph. 
Effect of Repeated Application  of SPA--Although  a  single dose of SPA was 
usually  without  effect  on  the  frog's  heart,  an  entirely  different  result  was 
obtained when  a  second dose  of SPA was  brought  into  contact  with  a  heart 
which  had  been  treated previously with  SPA.  The  response  of the  heart  to 
two doses is illustrated by the following experiment. 
The introduction into the heart of SPA in a  concentration of 1:25  was without effect' 
At the end of 5 minutes the solution was removed, and during the next 10 minutes the heart 
was twice washed with Ringer's solution.  Next, a second dose of SPA identical with the first 
was  introduced into the  Ftihner cannula.  Within 30 seconds  decreased  relaxation of the 
ventricle occurred  (Fig. 2A) and within 90 seconds  the heart underwent complete  systolic 
contracture. 
The  experiment shows  that  exposure  of the  heart  to  a  single dose of  SPA 
modified the heart in such  a  way that  it went into systolic contracture  when 
SPA was applied a second time.  There now arose the question of whether this 
effect could be explained by a  simple summation of two subthreshold doses or 
whether the first dose "sensitized  TM the heart to the second. 
A heart was exposed to activated SPA in a  concentration of 1:500  (Fig. 2B).  After 5 
minutes,  the heart was washed with two portions of Ringer's solution, and a second dose of 
activated SPA, 1 : 500, was applied.  The heart rapidly developed systolic contracture. 
In this experiment the total quantity of SPA applied to the heart was 0.004 
cc.  In  the  experiment  represented  by the  tracing reproduced  in  Fig.  2A  a 
single application of 0.04 cc. failed to produce systolic contracture.  Inasmuch 
as two applications of SPA accomplished an effect which was not produced by a 
single application representing ten times the sum of the  two doses, it is clear 
that the phenomenon is a true sensitization rather than the result of cumulative 
action.  Further indication that  the phenomenon  described consists in a  true 
sensitization is afforded by the observation that  even  after repeated washing 
during a period of 3 hours, the heart underwent contracture when exposed to a 
second small dose of SPA. 
As can be seen in Fig. 2B, the contracture produced by the second adminis- 
tration of activated SPA was  followed by spontaneous  recovery of the heart. 
This  spontaneous  recovery  which  is  due  to  the  rapid  inactivation  of  the 
hemolysin is dependent upon  the dose of the activated toxin used and is best 
observed when  a  small dose  of  toxin  is applied  to  the  heart  (compare  Figs. 
1 The word "sensitize" is not intended to connote sensitization in the immunological sense, 
but is here employed in accordance with general biological usage, that is, to render susceptible 
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2A  and  2B).  When a  third dose  of  activated  SPA was administered to  the 
recovered heart, systolic contracture again developed (not shown in figure). 
FIG. 2A 
FIG. 2B 
FiG. 2.  Sensitization of isolated heart  tO streptococcal preparation  A  (SPA).  Isolated 
frog's heart ~Straub) suspended on Ftihner's cannula: Ringer's solution 1.2 cc. Kymographic 
record of amplitude  of ventricular  contraction. 
(A)  At arrows--SPA  1  : 25 in cysteine 1  : 2500.  R, washing with Ringer's solution.  Fig- 
ures indicate in minutes the periods of arrest of the drum. 
(B)  At arrows--SPA  1  : 500 in cysteine 1  : 2500.  R, washing with Ringer's solution.  Fig- 
ures indicate in minutes the periods of arrest of the drum. 
Properties of the Active Principle of SPA.--Two characteristics of the substance 
which  acts  on the  heart  are  indicated in the  method  of preparation of  SPA, 
namely that it is non-dialyzable  and that it is salted out by saturated ammonium 
sulfate.  Evidence showing that  the  cardiotoxin is actually a  product  of  the 
streptococcus is presented in a  subsequent section. 
The active principle was  further characterized by the  results of  a  series of 
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The concentrations of SPA and of cysteine used were the same in the first (sensitizing) dose 
and in the second (contracture-producing) dose.  The two doses were applied  15 minutes 
apart,  and each was allowed to remain in the heart for 5 minutes.  The heart was washed 
twice with Ringer's solution between the first and the second dose. 
1.  Heat Lability.- 
Several cubic centimeters of the streptococcal preparation were diluted tenfold in Ringer's 
solution and heated for 10 minutes at 60  ° C.  The solution was cooled and diluted tenfold 
with  Ringer's  solution containing cysteine  (1:1000).  After  10  minutes  the  solution was 
further  diluted with  1.5 volumes of Ringer's fluid making the  final concentration  of SPA 
1:250.  Two doses of this dilution were found to be without effect on  the heart while the 
second of two administrations of an unheated control solution containing streptococcal prepa- 
ration in a concentration of 1:300 produced systolic contracture. 
This experiment, summarized in Table I,  shows  that  the  substance which 
acts on the heart is relatively thermolabile, all or most of its activity having 
been destroyed by exposure to 60  ° C. for 10 minutes. 
2.  Activation by Cysteine.--The purpose of  this experiment was  to  find out 
whether or not the substance acting on the heart was activated by cysteine. 
A fine stream of oxygen was bubbled for 8 minutes through several cubic centimeters of 
the streptococcal preparation diluted 1  : 10.  Two doses of the oxygen-treated material failed 
in a final concentration of 1:100 to affect the heart.  In order to see whether the oxygen- 
treated  preparation  could be activated  by cysteine, it was incubated in a concentration of 
1 : 20 with cysteine 1  : 250 for 5 minutes  in the cold.  Complete  systolic standstill was produced 
by this solution diluted  to a final concentration  of 1:200.  This concentration,  it may be 
noted, is only one-half that of the solution tested prior to activation with cysteine, the latter 
having been found to be inactive. 
This and similar experiments demonstrate that the substance which acts on 
the heart is activated by cysteine.  Control experiments showed that cysteine 
alone in a  concentration of 1:1000 when administered twice to the same heart 
did  not  produce  systolic  contracture.  Likewise,  a  solution containing heat- 
inactivated toxin plus cysteine failed to sensitize the heart to the action of SPA, 
and failed also to cause contracture of previously sensitized hearts. 
3.  Inhibition  by Cholesterol.--As  cholesterol is  known to  inactivate certain 
hemolytic and  cardiotoxic  agents  of  animal, plant,  and  bacterial origin,  the 
effect of cholesterol on the cardiotoxic activity of the streptococcal preparation 
was  investigated.  The  suspension of  cholesterol  was  prepared  according  to 
the method used by Cohen, Shwachman, and Perkins (17).  SPA was incubated 
with cholesterol 1 : 250,000 for 20 minutes in the cold prior to application to the 
heart.  SPA treated in this way was found to be inactive as can be seen from 
the results in Table I. 
4.  Inhibition  of  Action  of  SPA  by  Sera  Containing  A ntihemolysin.--The 
streptococcal  preparation  employed  in  this  study  contained a  hemolysin of 
high potency.  The hemolysin was markedly thermolabile, reversibly inactivated ALAN  W.  BERN'HEIMER  AND  G.  L.  CANTONI  301 
by oxygen, susceptible to  inhibition by cholesterol, and  could be  neutralized 
by antistreptococcal sera.  These properties are in agreement with the findings 
of Smythe and Harris (18), Herbert and Todd (19), and others who have studied 
TABLE I 
Prop~gies ~Ca~ioto~cFactor 
Nature of 
experiment 
Heat lability 
~.ctivation by 
cysteine 
Inhibition by 
cholesterol 
Treatment  of 
streptococcal 
preparation 
Strep. prep. 1  : 1O 
heated for 10 
rain. at 60  ° C. 
Unheated control 
Bubbled with Os 
for 8 min. 
Bubbled with 02 
for 8 min. 
Strep.  prep. 
1: 250  plus 
cysteine 
1:2500  plus 
cholesterol 
1 : 250,000 for 
20 min. in cold. 
Strep.  prep. 
1:250  plus 
cysteine 
1:2500  for  2C 
rain. in cold. 
Concentration of reagents during 
activation with cysteine 
Streptococcal 
prepara  tlon 
1:100 
Cysteine 
1:1000 
1:100  1:1000 
No activation with cysteine 
1:20  1:250 
1:100 
1:100 
1:1000 
1:1000 
Concentra-] 
tion of  [ 
strepto-  coccal  Effect of contrac- 
preparation  turing dose 
applied to 
heart* 
1 : 250  No  specific 
i  effect 
i 
1:250  i Almost  com. 
]  plete  systolic  I 
contracture 
1 : 100  No  specific 
effect 
1:200  Complete  sys. 
tolic contrac. 
ture 
I: 250  No  specific 
effect 
i  ! 
1:250  Complete  sys. 
tolic contrac. 
ture 
* Two administrations. 
the oxygen-labile hemolysin of the hemolytic streptococcus.  The similarity of 
the properties of the cardiotoxic factor, described in the foregoing paragraphs, 
to those of the oxygen-labile  hemolysin suggested that cardiotoxic and hemolytic 
actions may be functions  of a  single streptococcal product.  With these con- 
siderations in mind, experiments were done for the purpose of finding out whether 
antihemolytic sera can inhibit the cardiotoxic action of SPA. 302  CARDIAC  ACTION  OF  STNEPTOCOCCAL  TOXIN 
As has  been  emphasized previously, the application of SPA to  the normal 
frog's heart does not  result in systolic contracture but alters the state of the 
heart  in  such  a  way that  systolic contracture  occurs when  SPA is applied a 
second time.  In preliminary experiments it was found  that  the development 
of  systolic contracture  could  be  prevented  by  appropriate Concentrations  of 
antihemolytic sera.  It was also found that the application to a  normal heart 
of antihemolytic serum mixed with a  sensitizing dose of SPA did not result in 
sensitization of the heart.  These qualitative findings were extended to a roughly 
quantitative study in which  the capacity of sera to neutralize the cardiotoxic 
action of SPA was compared to the antihemolytic capacity of the sera. 
The capacity of a serum to inhibit systolic contracture was measured by mi~ing a series of 
dilutions of serum with a  contracture-producing dose of activated SPA, and applying the 
mixtures, after 3 minutes at room temperature, to hearts which had previously been sensitized 
to SPA.  For each serum, high concentrations inhibited systolic contracture while low con- 
centrations failed to inhibit.  Moreover,  it was possible to find a concentration which par- 
tially inhibited contracture; this concentration was selected as the endpoint of the titration. 
For technical reasons, precision greater than that attained by employing a series of twofold 
dilutions of serum was not sought.  The contracture-producing dose of SPA was the same in 
all the serum titrations and was equivalent in hemolytic units to twice the test dose employed 
in the titrations of antihemolytic action. 
Eight specimens of horse serum were titrated for anticardiotoxic and antihemolytic po- 
tencies.  The series included three specimens of normal horse serum, three specimens of anti- 
streptococcal serum,  and two of bivalent gas gangrene  antitoxin.  The antihemolytic po- 
tencies of the sera were measured by the method of Todd (20).  The test dose of hemolysin 
was 0.00033 cc. or 20 of our hemolytic units.  There was a thousandfoM  difference in anti- 
hemolytic potency between the strongest and the weakest serum.  This difference, as well as 
intermediate differences in antihemolytic action of the other six sera, were found to be paral- 
leled by the anticardiotoxic potencies (Table II). 
The normal horse sera showed the lowest antihemolytic power and also the 
weakest  anticardiotoxic  action.  The  antistreptococcal  sera  and  one  of  the 
specimens of gas gangrene antitoxin were the most potent inhibitors of hemolytic 
as well as of cardiotoxic action.  Considering the error inherent in the technique 
employed, the agreement between the two properties measured is quite good,-- 
actually better than was anticipated. 
Owing to difference in endpoints employed in the titrations of antihemolytic 
and anticardiotoxic potencies, the volumes of serum stated in Table II are those 
corresponding to  100  per cent neutralization of hemolytic activity and  to  50 
per cent neutralization of cardiotoxic activity of the test doses employed.  Since 
the test dose of toxin used in the titrations of cardiotoxic activity was  twice 
that  employed in  the  titrations of hemolytic  activity, the volumes  of serum 
representing the endpoints of the two  titrations  would be expected to be ap- 
proximately the  same.  As  can  be  seen  in  Table  II,  the  two  volumes  were 
approximately equal.  The  marked anticardiotoxic property of one of the gas 
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Type A, and the oxygen-labile hemolysin of Streptococcus  pyogenes have been 
shown to possess similar properties and to be immunologically related  (Todd 
(21)). 
As the antiscarlatinal potencies of two of the antistreptococcal sera, Le47H445 
and Le2745, were known, the capacity of these two sera to neutralize scarlatinal 
toxin on the one hand, and cardiotoxin on the other, could be  compared.  The 
ratio of anticardiotoxic power of the two sera  was 4.7 while the ratio of anti- 
scarlatinal power was 46, or approximately l0 times as great.  The anticardio- 
TABLE II 
Comparison of Antihemolytic and  Anticardiotoxic Potencies of  Various 
Specimens of Horse Serum 
Serum 
Normal horse serum No. 719 ................... 
Normal horse serum No. 746 ................... 
Normal horse serum No. 748 ................... 
Antistreptococcal serum Le47H445:~  ............. 
Antistreptococcal serum Le2745~t  .............. 
Antistreptococcal serum BL ................... 
Gas gangrene antitoxin EL .................... 
Gas gangrene antitoxin Cu .................... 
Amount of serum* 
required to neutralize 
hemolytic activity 
of SPA 
C¢, 
0.050 
0.059 
0.0034 
0.00024 
0.00062 
0.000050 
0.00074 
0.0023 
Amount of serum 
required to partially 
inhibit  cardiotoxic 
activity of SPA 
CC. 
0.050 
0.033 
0.0033 
0.00017 
0.00080 
0.000077 
0.00062 
0.0017 
* The reciprocal of these numbers equals the antistreptolysin-O  titer in Todd units per 
cubic centimeter  (20). 
Sera Le47H445 and Le2745 contained 6500 and 140 units per cc. of scarlet  fever anti- 
toxin, respectively.  This information as well as the two sera were kindly supplied by Dr. 
J. N. Adams, Jr.,  Lederle Laboratories, Inc.  We  axe  indebted  also  to  Dr.  H.  W.  Lyall 
and  Dr.  E.  Hazen,  New  York  State  Department of Health,  to Dr.  E.  W.  Todd,  the 
Wellcome Laboratories,  to  Eli Lilly and Co., and  to  the  Cutter Laboratories  for other 
samples of sera. 
toxic  capacities  of  the  two  sera  therefore  did  not parallel their  capacity  to 
neutralize scarlatinal toxin.  The ratio of antihemolytic power, however, is 2.6, 
and this is of the same order as the anticardiotoxic ratio of the two sera. 
DISCUSSION 
The cardiotoxic factor, so far as it has been studied, possesses the following 
properties: It is a non-dialyzable,  thermolabile product of Streptococcus  pyogenes 
which is activated by cysteine and which is inhibited by cholesterol.  Its action 
is inhibited by high  concentrations of normal horse  sera and by low concen- 
trations of  certain immune horse  sera.  The  anticardiotoxic potencies of  the 
sera studied were found to be directly proportiona[to their capacity to neutralize 304  CARDIAC  ACTION  Ole  STREPTOCOCCAL  TOXIN 
oxygen-labile hemolysin  of  Streptococcus  pyogenes.  These  findings  strongly 
suggest that the cardiotoxic factor is closely related to, perhaps identical with, 
the oxygen-labile hemolysin of the streptococcus. 
The pneumococcus, Cl. welchii,  and Cl. tetani are known to produce oxygen- 
labile hemolysins which resemble  closely that of the hemolytic streptococcus. 
It was therefore of interest to know whether the cardiotoxic factor is formed only 
by the streptococcus or by these bacteria as well. ~ Although this point has not 
been thoroughly investigated, preliminary observations indicate that the cardio- 
toxic factor is not peculiar to  the streptococcus alone.  The hemolysin of a 
rough variant of pneumococcus, Type II, strain D39, prepared by the method 
of Cohen, Halbert, and Perkins (22) produced effects on the frog's heart which 
were indistinguishable from those of the streptococcal preparation.  Likewise 
a preparation of Cl. welchii theta toxin,  ~ which contained little or no alpha toxin, 
had an action on the heart similar to that of the streptococcal toxin.  These 
results indicate that the sensitization described in this paper has bearing on the 
toxic action not only of the streptococcus but of other bacteria as well. 
Such chemically diverse compounds as the cardiac glycosides and bile acids 
(23),  the polypeptide tyrocidin (24), oxidizing agents (6, 25),  and calcium ions 
are  capable  of  producing  systolic  contracture  of  the  isolated  frog's  heart. 
Although certain bacterial toxins, notably the toxin of Cl. septicum and one of 
the toxins, presumably alpha toxin, of Cl. welchii are known to induce systolic 
standstill of the frog's heart, their action takes place only after a latent period 
and  the  systolic standstill which develops is  irreversible.  The  streptococcal 
toxin differs from most of the above substances in inducing a systolic contracture 
which is rapid in development and which is reversible.  Its capacity to sensitize 
the heart to subsequent application of this toxin is an additional property which 
to the best of our knowledge is not possessed  by other agents. 
A phenomenon consisting in the sensitization of intestinal smooth muscle to 
cysteine by previous exposure of the tissue to this amino acid or to cystine was 
described by Voegtlin and Dyer  (26).  Since cysteine is one of the reagents 
employed in our experiments and since the sensitization which we have described 
bears  a  striking  resemblance  to  that  discovered by Voegtlin  and  Dyer,  the 
possibility of a  close  relationship between the  two phenomena was carefully 
considered.  Experiments in which  we attempted to produce systolic contracture 
of the heart by means of two applications of cysteine alone, or by sensitizing the 
heart with SPA and attempting to induce contracture with cysteine alone, and 
vice versa, were negative.  In view of these results there does not seem to be 
more than a superficial similarity between our observations on the frog's heart 
and those of Voegtlin and Dyer on smooth muscle. 
What relationship, if any, the sensitization described in this paper may have 
to the pathogenesis of streptococcal infections remains obscure.  It should be 
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emphasized that the effects of a toxin on an isolated organ need not be neces- 
sarily transferable to an intact organism, and that the observed response of 
the isolated frog's heart to a bacterial product may not have a direct counter- 
part in the mammalian heart.  However, the fact that streptococcal hemolysin 
or a  substance indistinguishable from it sensitizes the heart  in  the manner 
described and affects the contractile mechanism of the frog's heart has been 
clearly shown.  It is thereby demonstrated that the action of this bacterial 
product is not limited to the lysis of blood cells. 
SUMMARY 
1.  A  study has been made of the effect on the isolated frog's heart of a 
preparation derived from the supernatant fluid of cultures of hemolytic strep- 
tococcus. 
2.  The streptococcal preparation was found to induce systolic contracture, 
the contracture usually developing only after the second of two administrations 
of the preparation.  It was found that a single application of the streptococcal 
preparation sensitized the heart to a  second application. 
3.  The properties of the cardiotoxic factor so far as they have been studied 
were found to be identical with those of the oxygen-labile hemolysin of strep- 
tococci.  The capacity of normal and of immune sera to neutralize the cardio- 
toxic action paralleled the antihemolytic potency of the sera. 
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